DrugPatentWatch Database Preview
Drugs in Development Information for Isoquinoline
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
What is the development status for investigational drug Isoquinoline?
Isoquinoline is an investigational drug.
There have been 11 clinical trials for Isoquinoline.
The most recent clinical trial was a Phase 1 trial, which was initiated on July 1st 2018.
The most common disease conditions in clinical trials are Cysticercosis, HIV Infections, and Taeniasis. The leading clinical trial sponsors are National Institute of Mental Health (NIMH), Tianjin Anding Hospital, and xiaohua li.
There are nine hundred and ninety-five US patents protecting this investigational drug and nine international patents.
Summary for Isoquinoline
| US Patents | 995 |
| International Patents | 9,924 |
| US Patent Applications | 8,538 |
| WIPO Patent Applications | 0 |
| Japanese Patent Applications | 95 |
| Clinical Trial Progress | Phase 1 (2018-07-01) |
| Vendors | 85 |
Recent Clinical Trials for Isoquinoline
| Title | Sponsor | Phase |
|---|---|---|
| Comparation of Berberine and Metformin for the Treatment for MS in Schizophrenia Patients | Tianjin Anding Hospital | Phase 4 |
| Assessing Goldenseal-drug Interactions Using a Probe Drug Cocktail Approach | National Center for Complementary and Integrative Health (NCCIH) | Early Phase 1 |
| Assessing Goldenseal-drug Interactions Using a Probe Drug Cocktail Approach | Washington State University | Early Phase 1 |
Clinical Trial Summary for Isoquinoline
Top disease conditions for Isoquinoline
Top clinical trial sponsors for Isoquinoline
US Patents for Isoquinoline
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Isoquinoline | Start Trial | Production method of 1, 2, 4-triazole compound | Sumitomo Chemical Company, Limited (Tokyo, JP) | Start Trial |
| Isoquinoline | Start Trial | Substituted 4,5,6,7-tetrahydropyrazolo[3,4-c]pyridines as factor XIa inhibitors | Bristol-Myers Squibb Company (Princeton, NJ) | Start Trial |
| Isoquinoline | Start Trial | Crystalline dimethyl 3-(benzyloxy)-1-(2,2-dimethoxyethyl)-4-oxo-1,4-dihydropyridine-2,5-dicarb- oxylate | Shionogi & Co., Ltd (JP) | Start Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Isoquinoline
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Isoquinoline | Japan | 2017186325 | 2036-03-31 | Start Trial |
| Isoquinoline | China | 103987697 | 2031-10-14 | Start Trial |
| Isoquinoline | European Patent Office | 2766345 | 2031-10-14 | Start Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
